Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

NsGene A/S - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 24 | Code: MRS - 18611

Product Synopsis

NsGene A/S Product Pipeline Review 2014


Global Markets Directs, NsGene A/S Product Pipeline Review 2014, provides an overview of the NsGene A/Ss pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NsGene A/Ss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


The report provides brief overview of NsGene A/S including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of NsGene A/Ss human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the NsGene A/Ss pipeline products

Reasons to buy

Evaluate NsGene A/Ss strategic position with total access to detailed information on its product pipeline
Assess the growth potential of NsGene A/S in its therapy areas of focus
Identify new drug targets and therapeutic classes in the NsGene A/Ss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of NsGene A/S and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of NsGene A/S
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of NsGene A/S and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
NsGene A/S Snapshot 4
NsGene A/S Overview 4
Key Information 4
Key Facts 4
NsGene A/S- Research and Development Overview 5
Key Therapeutic Areas 5
NsGene A/S- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Pipeline Products- Out-Licensed Products 9
Out-Licensed Products/Combination Treatment Modalities 10
NsGene A/S- Pipeline Products Glance 11
NsGene A/S- Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
NsGene A/S- Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
NsGene A/S- Drug Profiles 13
NsG-0202 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NsG-0301 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
NsG-33 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
NsGene A/S- Pipeline Analysis 16
NsGene A/S- Pipeline Products by Target 16
NsGene A/S- Pipeline Products by Route of Administration 17
NsGene A/S- Pipeline Products by Molecule Type 18
NsGene A/S- Pipeline Products by Mechanism of Action 19
NsGene A/S- Recent Pipeline Updates 20
NsGene A/S- Dormant Projects 21
NsGene A/S- Locations And Subsidiaries 22
Head Office 22

Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables

NsGene A/S, Key Information 4
NsGene A/S, Key Facts 4
NsGene A/S- Pipeline by Indication, 2014 6
NsGene A/S- Pipeline by Stage of Development, 2014 7
NsGene A/S- Monotherapy Products in Pipeline, 2014 8
NsGene A/S- Out-Licensed Products in Pipeline, 2014 9
NsGene A/S- Out-Licensed Products/ Combination Treatment Modalities, 2014 10
NsGene A/S- Phase I, 2014 11
NsGene A/S- Preclinical, 2014 12
NsGene A/S- Pipeline by Target, 2014 16
NsGene A/S- Pipeline by Route of Administration, 2014 17
NsGene A/S- Pipeline by Molecule Type, 2014 18
NsGene A/S- Pipeline Products by Mechanism of Action, 2014 19
NsGene A/S- Recent Pipeline Updates, 2014 20
NsGene A/S- Dormant Developmental Projects,2014 21

List of Figures

NsGene A/S - Pipeline by Top 10 Indication, 2014 6
NsGene A/S - Pipeline by Stage of Development, 2014 7
NsGene A/S - Monotherapy Products in Pipeline, 2014 8
NsGene A/S - Pipeline by Top 10 Target, 2014 16
NsGene A/S - Pipeline by Top 10 Route of Administration, 2014 17
NsGene A/S - Pipeline by Top 10 Molecule Type, 2014 18
NsGene A/S - Pipeline Products by Top 10 Mechanism of Action, 2014 19

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing